Jinghua Pharmaceutical Group Co., Ltd. (China)

Nantong Jinghua Pharmaceutical Ltd. Co. was established in2002, with total asset of RMB250 million. The occupied areais 140000M2. Now there are 1000 employees. The annualturnover is close to RMB300 million.The production histories of both Nantong GeneralPharmaceutical Factory and Nantong Zhongcheng PharmaceuticalCo. are about 50 years.Now, Nantong Jinghua Pharmaceutical Co., Ltd, as acomprehensive pharmaceutical manufacturer, is a dominantenterprise in pharmaceutical researching, developing,manufacturing and trading fields for active pharmaceuticalingredients (APIs), intermediates, formulations andtraditional Chinese medicines.There are about 200 kinds of formulation products withforms of injection, tablets, capsules, pills, granular,powder and syrup. In which the historical famous Ji DeshengBrand: "Ji Desheng Antivenom Tablets"; Nantong Brand:"Wang's Baby-health Pill"; Ning Ning Brand: "ZhengChaihuying Granule" and the State protected traditionalChinese medicines: "Gu Beng Ke Chuang Tablets", "Yun Ke PingSyrup" and "Jing Qiao Mai Tablets" etc. are famous both inhome and abroad markets.The main APIs are Phenobarbital, Primidone,5-Fluorouracil, 5-Flucytosine, Phenylbutazone, Piroxicam,Aminoglutethimide, Tenoxicam, Propylthiouracil, MoxonidineHCl and their intermediates and derivatives. At present,Atorvastatin Calcium, Olistat, Entricitabine, Isoflurane,Meropenem and other new products are being developed. Inwhich 5-Fluorouracil is approved COS in 2000 andPhenylbutazone is approved COS in Oct., 2006. The COSapplications for Phenobarbital and Primidone are being done.The annual capacity: 1000 tons active pharmaceuticalingredients and intermediates, 2000 tons herb extraction,1000 tons granular, 1.5 billion tablets, 120 million ampouleinjections and 80 million capsules. Good ManufacturingPractices (GMP) is strictly implemented in the wholeproduction. And the quality of products comply with thestandards of CP, Ph. Eur., USP, BP and/or standards requiredby customers.